Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens

Chelation of fresh human serum with 0.01 M MgCl2 (Mg) plus 0.01 M ethylene glycol tetraacetic acid failed to abrogate the bactericidal activity against "delayed serum-sensitive" strains of Serratia marcescens, whereas previously "promptly serum-sensitive" strains of S. marcescens and control strain Escherichia coli C were killed after an extended period of incubation. The addition of 0.01 M ethylenediametetracetate to fresh human serum neutralized bactericidal activity against S. marcescens of either serum sensitivity category.

[1]  W. Traub,et al.  Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum. , 1976, Chemotherapy.

[2]  J. Hawiger,et al.  Function of the Classical and Alternate Pathways of Human Complement in Serum Treated with Ethylene Glycol Tetraacetic Acid and MgCl2-Ethylene Glycol Tetraacetic Acid , 1975, Infection and immunity.

[3]  P. Schur,et al.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. , 1975, The New England journal of medicine.

[4]  R. Snyderman,et al.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption , 1975, Infection and immunity.

[5]  M. Frank,et al.  Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. , 1975, Clinical immunology and immunopathology.

[6]  W. Traub,et al.  Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens. , 1975, Chemotherapy.

[7]  A. Forsgren,et al.  Influence of the Alternate Complement Pathway on Opsonization of Several Bacterial Species , 1974, Infection and immunity.

[8]  D. Fine.  Activation of the classic and alternate complement pathways by endotoxin. , 1974, Journal of immunology.

[9]  S. Marney,et al.  C3 shunt activation in human serum chelated with EGTA. , 1972, Journal of immunology.

[10]  A. G. Osler,et al.  Dual pathways of complement interaction with guinea pig immunoglobulins. , 1971, Journal of immunology.

[11]  I. Lepow,et al.  Functional relationship of factor B in the properdin system to C3 proactivator of human serum. , 1971, Journal of immunology.

[12]  O. Götze,et al.  THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION , 1971, The Journal of experimental medicine.

[13]  W. Traub.  Assay of the antibiotic activity of serum. , 1969, Applied microbiology.